Sun, Roger https://orcid.org/0000-0001-9866-6449
Sundahl, Nora
Hecht, Markus https://orcid.org/0000-0003-2082-216X
Putz, Florian
Lancia, Andrea
Rouyar, Angela
Milic, Marina
Carré, Alexandre
Battistella, Enzo
Alvarez Andres, Emilie
Niyoteka, Stéphane
Romano, Edouard
Louvel, Guillaume
Durand-Labrunie, Jérôme
Bockel, Sophie
Bahleda, Rastilav
Robert, Charlotte https://orcid.org/0000-0001-8838-1343
Boutros, Celine https://orcid.org/0000-0001-5659-8791
Vakalopoulou, Maria
Paragios, Nikos
Frey, Benjamin https://orcid.org/0000-0001-6743-3351
Soria, Jean-Charles
Massard, Christophe
Ferté, Charles
Fietkau, Rainer
Ost, Piet
Gaipl, Udo https://orcid.org/0000-0001-6375-5476
Deutsch, Eric
Clinical trials referenced in this document:
Documents that mention this clinical trial
Monocyte/lymphocyte ratio to predict immunoradiotherapy response in patients with advanced pretreated sarcoma.
https://doi.org/10.1200/jco.2024.42.16_suppl.e23523
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells
https://doi.org/10.1136/jitc-2020-001429
Documents that mention this clinical trial
Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma
https://doi.org/10.1136/jitc-2020-000627
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells
https://doi.org/10.1136/jitc-2020-001429
Documents that mention this clinical trial
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response
https://doi.org/10.1186/s12967-017-1123-x
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells
https://doi.org/10.1136/jitc-2020-001429
Documents that mention this clinical trial
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells
https://doi.org/10.1136/jitc-2020-001429
Documents that mention this clinical trial
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells
https://doi.org/10.1136/jitc-2020-001429
Documents that mention this clinical trial
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells
https://doi.org/10.1136/jitc-2020-001429
Funding for this research was provided by:
Amazon AWS grant
SIRIC-SOCRATE 2.0 (grant INCa-DGOS-INSERM_12551)
Fondation ARC pour la Recherche sur le Cancer (grant SIGN'IT20181007805)
Fondation pour la Recherche Médicale (grant DIC20161236437)
INSERM in partnership with Fondation Bettencourt Schueller (CCA-INSERM-BETTENCOURT)